Mutsa Madondo
0000-0002-0958-6314
Publication & Citation Trends
Most Cited Works
Publications
18 total
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial PDF
Cited by 2
OpenAlex
Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses PDF
Cited by 11
OpenAlex
PP.02 Tyrosine Kinase Inhibitor (TKI) Real-World Use in Epidermal Growth Factor Receptor Mutated (EGFRm) Advanced Non-small Cell Lung Cancer (NSCLC) Patients
Cited by 0
OpenAlex
26P Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries OA
Cited by 2
Semantic Scholar
Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer PDF
Cited by 50
OpenAlex
Sperm Protein 17 Expression by Murine Epithelial Ovarian Cancer Cells and Its Impact on Tumor Progression PDF
Cited by 13
OpenAlex
Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells PDF
Cited by 72
OpenAlex
A flowcytometric analysis to efficiently quantify multiple innate immune cells and <scp>T</scp> Cell subsets in human blood PDF
Cited by 26
OpenAlex
Research Topics
Ovarian cancer diagnosis and treatment
(9)
Immune Cell Function and Interaction
(8)
Reproductive System and Pregnancy
(4)
T-cell and B-cell Immunology
(3)
Cancer Immunotherapy and Biomarkers
(3)
Frequent Co-Authors
Affiliations
University of Western Australia
The Alfred Hospital
Monash Alfred Psychiatry Research centre
Monash University
RMIT University